Katz RL, He W, Khanna A, Fernandez RL, Caraway NP, Zhang H, Spitz MR, Blowers DP, Jimenez CA, Mehran RJ, Swisher SG , Roth JA, Etzel C, El-Zein R
Administered subcutaneously, its injectable form is rapidly absorbed and distributed to metabolically active tissues, where it specifically binds and inhibits NNMT catalytic activity without interfering with other enzymes in the nicotinamide pathway or NAD+ synthesis
Inform your clinician if you are using: Insulin or diabetes medications Growth hormone or IGF-1 therapies Corticosteroids Other injectable peptides or hormone-modulating treatments Common questions (FAQ) Why is Ipamorelin considered selective
Effect of antihypertensive medication on cerebral small vessel disease: a systematic review and meta-analysis
It is not a medical treatment for any condition